In comparison with non-biologic anti-inflammatory medications, 4822 anti-TNF-α initiators demonstrated no difference in crude or adjusted rates of incident hypertension (HR: 0.95, 95% CI: 0.74–1.2),163 results supported by a smaller Korean cohort of 996 patients with RA.164. The gene discussed is TNF; the disease is hypertensive disorder.